Exploring the interactive mechanism of acarbose with the amylase SusG in the starch utilization system of the human gut symbiont Bacteroides thetaiotaomicron through molecular modeling

The α‐amylase, SusG, is a principal component of the Bacteroides thetaiotaomicron (Bt) starch utilization system (Sus) used to metabolize complex starch molecules in the human gastrointestinal (GI) tract. We previously reported the non‐microbicidal growth inhibition of Bt by the acarbose‐mediated ar...

Full description

Saved in:
Bibliographic Details
Published in:Chemical biology & drug design 2023-09, Vol.102 (3), p.486-499
Main Authors: Kwain, Samuel, Dominy, Brian N., Whitehead, Kristi J., Miller, Brock A., Whitehead, Daniel C.
Format: Article
Language:English
Subjects:
acarbose
Bacteroides thetaiotaomicron
molecular modeling
SusG
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The α‐amylase, SusG, is a principal component of the Bacteroides thetaiotaomicron (Bt) starch utilization system (Sus) used to metabolize complex starch molecules in the human gastrointestinal (GI) tract. We previously reported the non‐microbicidal growth inhibition of Bt by the acarbose‐mediated arrest of the Sus as a potential therapeutic strategy. Herein, we report a computational approach using density functional theory (DFT), molecular docking, and molecular dynamics (MD) simulation to explore the interactive mechanism between acarbose and SusG at the atomic level in an effort to understand how acarbose shuts down the Bt Sus. The docking analysis reveals that acarbose binds orthosterically to SusG with a binding affinity of −8.3 kcal/mol. The MD simulation provides evidence of conformational variability of acarbose at the active site of SusG and also suggests that acarbose interacts with the main catalytic residues via a general acid–base double‐displacement catalytic mechanism. These results suggest that small molecule competitive inhibition against the SusG protein could impact the entire Bt Sus and eliminate or reduce the system's ability to metabolize starch. This computational strategy could serve as a potential avenue for structure‐based drug design to discover other small molecules capable of inhibiting the Sus of Bt with high potency, thus providing a holistic approach for selective modulation of the GI microbiota. Molecular docking and molecular dynamics calculations describe the binding interaction of the drug acarbose with the membrane‐bound amylase, SusG, of the starch utilization system resident in Bacteroides thetaiotaomicron.
ISSN:1747-0277
1747-0285
DOI:10.1111/cbdd.14251